Abstract: A compound of formula (I): wherein: M is hydrogen or a pharmaceutically acceptable salt-forming cation; and R1 and M are as defined herein. Also, methods of treating bacterial infection, pharmaceutical compositions, molecular complexes and processes for preparing compounds.

Abstract: A compound of formula (I) or formula (Ia) Wherein R1, Ra, R2, X, R3, Y1, Y2, A, B and C are as defined herein. Also, pharmaceutical compositions comprising such compounds and excipients, methods of treating bacterial infections comprising administering such compounds, methods for making such compounds and hydrates of such compounds.

Abstract: A system for identifying usage of a target data element including both direct and indirect usage, within a data element structure where the target data element may have more than one parent data element. The system includes a usage processing engine configure to identify direct and indirect usage data elements for the target data element within the data element structure and a user interface configured to display the direct and indirect usage data elements for the target element in a hierarchical structure.

Abstract: A system for generating embedded expressions configured to generate a result. The system includes an embedded expression generation engine configured to generate a root expression, including at least one parameter. The parameter includes an assigned embedded expression configured to generate a result based on one or more input parameters. The system further includes an embedded expression user interface configured to display the root expression and associated parameters and embedded expressions and provide expression generation tools allowing the user to modify the root expression.

Abstract: A system for identifying usage of a target data element including both direct and indirect usage, within a data element structure where the target data element may have more than one parent data element. The system includes a usage processing engine configure to identify direct and indirect usage data elements for the target data element within the data element structure and a user interface configured to display the direct and indirect usage data elements for the target element in a hierarchical structure.

Abstract: A system for generating embedded expressions configured to generate a result. The system includes an embedded expression generation engine configured to generate a root expression, including at least one parameter. The parameter includes an assigned embedded expression configured to generate a result based on one or more input parameters. The system further includes an embedded expression user interface configured to display the root expression and associated parameters and embedded expressions and provide expression generation tools allowing the user to modify the root expression.

Abstract: Antibacterial 3-aminoquinazolin-2,4-diones have formula (1) wherein: R1 and R3 include alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclic, and heteroaryl; R5, R6, and R8 include H, alkyl, alkoxy, halo, NO2, CN, NH2, alkyl and dialkylamino; R7 includes hydrogen, alkyl, cycloalkyl, heterocyclic, fused heterocyclic, aryl and fused aryl; J and K are C or N; and pharmaceutically acceptable salts thereof.

Abstract: Antibacterial 3-aminoquinazolin-2,4-diones have formula (I) wherein: R1 and R3 include alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclic, and heteroaryl; R5, R6, and R8 include H, alkyl, alkoxy, halo, NO2, CN, NH2, alkyl and dialkylamino; R7 includes hydrogen, alkyl, cycloalkyl, heterocyclic, fused heterocyclic, aryl and fused aryl; J and K are C or N; and pharmaceutically acceptable salts thereof.

Abstract: The present invention provides compounds of Formula (I): wherein R1-R6 and K have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antibacterial agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.

Abstract: A system of computer manufacturing with pre-installation of software which utilizes a software selection process controlled by a rules database to determine the proper software components to be pre-installed onto an assembled computer or hard drive. Additionally, the rules base determines the appropriate diagnostic and set-up software components to be installed in order to ensure a system that is ready-to-run upon receipt by a purchaser.

Abstract: A compound of formula I, or an optical isomer or pharmaceutically acceptable salt thereof, ##STR1## is disclosed as well as a pharmaceutical composition and a method of treating or preventing a fungal infection using the compound.

Abstract: A process for the mass production of computers where software is automatically installed according to configure-to-order requirements. Additionally, the process captures the as-built hardware and software components of each computer for the vendor service and support program. Furthermore, the process provides a software installation environment which is secure from any undetectable alteration and offers control and auditing of subcontractors who produce systems according to manufacturer's specifications. Finally, the process automates the tracking and reporting of royalty payments to the appropriate recipient.

Abstract: A computer manufacturing architecture in which a single software database feeds both direct downloading and surrogate downloading through a common network.

Abstract: A process for the synthesis of compounds of the formulas Ia and Ib below, wherein R.sub.1, R.sub.2, and R.sub.3, which are the same or different, are each selected from hydrogen and C.sub.1 -C.sub.4 alkyl, including the compound Anabaseine (Ia, wherein R.sub.1 =R.sub.2 R.sub.3 =H) (3,4,5,6-tetrahydro-2', 3'-bipyridine), the process comprising reacting sodium salt of .delta.-valerolactone with substituted ethyl nicotinate derivative to produce the Claisen product sodium 3-nicotinoyl-2-tetrahydropyranone enolate derivative, heating the sodium 3-nicotinoyl-2-tetrahydropyranone enolate derivative with concentrated HCl to produce 3-(5-chloro-1-pentanone-1-yl) pyridine derivative, dissolving the 3-(5-chloro-1-pentanone-1-yl) pyridine derivative in ethanol and then heating the 3-(5-chloro-1-pentanone-1-yl) pyridine derivative in ethanol with ethanolic ammonia solution in a sealed container to produce the compound Ia.